Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,010
Ph III recruiting: 99
Growth YoY: −1.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,348)

clinicaltrialsPublishedShowing 851–863 of 863 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01744223	Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant	active not recruiting	Phase 1 / Phase 2	36	Bellicum PharmaceuticalsINDUSTRY	1	Jul 12, 2022	clinicaltrials
NCT03301168	Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant	active not recruiting	Phase 1 / Phase 2	120	Bellicum PharmaceuticalsINDUSTRY	1	Jul 12, 2022	clinicaltrials